Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 19, 2002 - Issue 4
Submit an article Journal homepage
35
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: Evaluation of formulation variables on microspheres characteristics for brain delivery

B. Arica Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 06100 Sıhhiye-Ankara, Turkey
,
H. S. Kaş Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 06100 Sıhhiye-Ankara, Turkey
,
M. N. Orman Ankara University, Faculty of Veterinary Medicine, Department of Biostatistics, 06110 Dışkapı-Ankara, Turkey
&
A. A. Hincal Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 06100 Sıhhiye-Ankara, Turkey
Pages 473-484 | Published online: 29 Sep 2008

  • AÇIKGU+022EZ, M., KAS, H. S., ORMAN, M., and HINCAL, A. A., 1996, Chitosan microspheres of diclofenac sodium: I. Application of factorial design and evaluation of release kinetics. Journal of Microencapsulation, 13, 141-160.
  • ALEX, R., and BODMEIER, R., 1990, Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. Journal of Microencapsulation, 7, 347-355.
  • ARICA, B., KAS, H. S., and HINCAL, A. A., 1997, Evaluation and formulation of biodegradable levodopa microspheres using 32 factorial design. In Biomedical Science and Technology. Recent Developments in the Pharmaceutical and Medical Sciences, edited by A. A. Hincal and H.S. Kas(New York and London: Plenum Press), pp. 41-49.
  • ARICA, B., KAS, H. S., ORMAN, M., ÇELIK, H. H., and HINCAL, A. A., 1996, Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I. Evaluation of formulation parameters using 32 factorial design. Proceedings of the 8th International Pharmaceutical Technology Symposium (IPTS-96), 9-11 September, pp. 167-168.
  • ARICA, B., KAS, H. S., SARGON, M. F., AÇIKG×Z, B., and HINCAL, A. A., 1999, Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. II. Suitability for brain and hypophysis delivery. S.T.P. Pharma Sciences, 9, 447455.
  • ARSHADY, R., 1991, Preparation of biodegradable microspheres and microcapsules: 2. Polylactides and related polyesters. Journal of Controlled Release, 17, 1-22.
  • ATKINS, T. W., PEACOCK, S. J., and YATES, D. J., 1998, Incorporation and release of vancomycin from poly(D,L-lactide-co-glycolide) microspheres. Journal of Microencapsulation, 15, 31-44.
  • BENOIT, J. P., FAISANT, N., VENIER-JULIENNE, M. C., and MENEI, P., 2000, Development of microspheres for neurological disorders: from basics to clinical applications. Journal of Controlled Release, 65, 285-296.
  • BODMEIER, R., and MCGINITY, J. W., 1987, Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II: Some process parameters influencing the preparation and properties of the microspheres. Journal of Microencapsulation, 4, 289-297.
  • BODMEIER, R., and McGINITY, J. W., 1988, Solvent selection in the preparation of poly(DLlactide) microspheres prepared by the solvent evaporation method. International Journal of Pharmaceutics, 43, 179-186.
  • CHEN, H., Wu, J. C., and CHEN, H. Y., 1995, Preparation of ethylcellulose microcapsules containing theophylline by using emulsion non-solvent addition method. Journal of Microencapsulation, 12, 137-147.
  • COHEN, S., YOSHIOKA, T., LUCARELLI, M., HWANG, L. H., and LANGER, R., 1991, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharmaceutical Research, 8, 713-720.
  • HUATAN, H., COLLETT, J. H., and ATTWOOD, D., 1995, The microencapsulation of protein using a novel ternary blend based on poly(e-caprolactone). Journal of Microencapsulation, 12, 557-567.
  • IWATA, M., and MCGINITY, J. W., 1993, Dissolution, stability and morphological properties of conventional and multiphase poly(DL-lactic-co-glycolic acid) microspheres containing water-soluble compounds. Pharmaceutical Research, 10, 1219-1227.
  • JALIL, R., 1990, Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) polymers in sustained drug delivery. Drug Development and Industrial Pharmacy, 16, 2353-2367.
  • MANIJEH, F., KAS, H. S., ÖNER, L., and HINCAL, A. A., 1993, Factorial design-based optimization of the formulation of isosorbide-5-mononitrate microcapsules. Journal of Microencapsulation, 10, 309-317.
  • MENDENHALL, W., 1968, Introduction to Linear Models and The Design and Analysis of Experiments (California: Wadsworth Publishing Company Inc.).
  • O'DONNELL, P. B., and McGINITY, J. W., 1998, Influence of processing on the stability and release properties of biodegradable microspheres containing thioridazine hydrochloride. European Journal of Pharmacy and Biopharmaceutics, 45, 83-94.
  • OKADA, H., and TOGUCHI, H., 1995, Biodegradable microspheres in drug delivery. CRC Critical Reviews of Therapeutic Drug Carrier Systems, 12, 1-99.
  • The Merck Index, 1989, 11th edn (Rahway, NJ: Merck and Co., Inc.), p. 214.
  • TORRES, A. I., BOISDRON-CELLE, M., and BENOIT, J. P., 1996, Formulation of BCNU-loaded microspheres: influence of drug stability and solubility on the design of the microencapsulation procedure. Journal of Microencapsulation, 13, 41-51.
  • VANCE, M. L., EVANS, W. S., and THORNER, M. O., 1984, Bromocryptine. Annals of International Medicine, 100, 78-91.
  • WANG, H. T., PALMER, H., LINHARDT, R. J., FLANAGAN, D. R., and SCHMITT, E., 1990, Degradation of poly(ester) microspheres. Biomaterials, 11, 679-685.
  • WATTS, P. J., DAVIES, M. C., and MELIA, C. D., 1990, Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. CRC Critical Reviews of Therapeutic Drug Carrier Systems, 7, 235-258.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.